| Authors: |
Seal S; Broad Institute of MIT and Harvard, Cambridge, MA, USA. seal@broadinstitute.org.; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK. seal@broadinstitute.org., Trapotsi MA; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Cambridge, UK. marianna.trapotsi1@astrazeneca.com., Spjuth O; Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Phenaros Pharmaceuticals AB, Uppsala, Sweden., Singh S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Carreras-Puigvert J; Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.; Phenaros Pharmaceuticals AB, Uppsala, Sweden., Greene N; Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Waltham, MA, USA., Bender A; Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, UK.; STAR-UBB Institute, Babeş-Bolyai University, Cluj-Napoca, Romania., Carpenter AE; Broad Institute of MIT and Harvard, Cambridge, MA, USA. anne@broadinstitute.org. |
